PET/CT in the evaluation of inflammatory bowel disease: Studies in patients before and after treatment

Molecular Imaging and Biology

Volumn 12, Issue 1, 2010, Pages 85-88

  Spier, Bret J ^a   Perlman, Scott B ^a   Jaskowiak, Christine J ^a   Reichelderfer, Mark ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Crohn's colitis; Inflammatory bowel disease; PET CT; Treatment; Ulcerative colitis

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; BUDESONIDE; FLUORODEOXYGLUCOSE F 18; HYDROCORTISONE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENTERITIS; HUMAN; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOM; ULCERATIVE COLITIS;

ADULT; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77149138854     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-009-0232-1     Document Type: Article

References (10)

1. 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease Lancet 354 836 837 1:STN:280:DyaK1MvhtlOnsQ%3D%3D 10485733 PMID: 10485733
2. DA Lemberg RM Issenman R Cawdron, et al. 2005 Positron emission tomography in the investigation of pediatric inflammatory bowel disease Inflamm Bowel Dis 11 733 738 10.1097/01.MIB.0000172810.49619.cb 16043988 PMID 16043988 (Pubitemid 41271177)
3. 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies Am J Gastroenterol 97 1978 1985 10.1111/j.1572-0241.2002.05836.x 1:STN:280:DC%2BD38vjtlKlsw%3D%3D 12190164 PMID: 12190164
4. 18F]fluoro-d-glucose-labeled white blood cells Mol Imaging Biol 5 271 277 10.1016/S1536-1632(03)00103-3 14499142 PMID: 14499142 (Pubitemid 37074878)
5. 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease Ann N Y Acad Sci 1072 379 385 10.1196/annals.1326.014 17057218 PMID: 17057218 (Pubitemid 44448470)
6. RS Meisner BJ Spier S Einarsson, et al. 2007 Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease Inflamm Bowel Dis 13 993 1000 10.1002/ibd.20134 17394243 PMID: 17394243 (Pubitemid 47309971)
7. E Louis G Ancion A Colard V Spote J Belaiche R Hustinx 2007 Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT J Nucl Med 48 1053 1059 10.2967/jnumed.107.040436 17574978 PMID: 17574978 (Pubitemid 47052642)
8. WR Best JM Becktel JW Singleton F Kern Jr 1976 Development of a Crohn's disease activity index. National cooperative Crohn's disease study Gastroenterology 70 439 444 1:STN:280:DyaE287hvVGmtg%3D%3D 1248701
9. L Sutherland J Singleton J Sessions, et al. 1991 Double blind, placebo controlled trial of metronidazole in Crohn's disease Gut 32 1071 1075 10.1136/gut.32.9.1071 1:STN:280:DyaK38%2FgvFCktQ%3D%3D 1916494
10. RF Harvey JM Bradshaw 1980 A simple index of Crohn's-disease activity Lancet 1 514 10.1016/S0140-6736(80)92767-1 1:STN:280:DyaL3c7kt1Wjtg%3D%3D 6102236